MedPath
NMPA Approval

Rifampicin Capsules

国药准字H21020043

January 7, 2021

Drug Information

利福平胶囊

胶囊剂

0.15g

化学药品

January 7, 2021

Company Information

Applicant Company

Manufacturing Company

锦州经济技术开发区锦港大街东贵阳路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福平胶囊 - NMPA 批准文号 | MedPath